Allt inom Report

Nanexa publishes interim report for January – June 2022

The pilot plant inaugurated and GMP certified, patent approved in Europe and product projects approaching clinical phase

Nanexa publishes interim report for January – March 2022

Positive development in the product projects and in the patent portfolio